When Rachel Dreilinger co-founded NeuraMedica, she wasn’t just setting out to solve a surgical problem. She was aiming to change the way innovation works for patients, providers, and underrepresented entrepreneurs like herself.

A biomedical engineer by training and a systems thinker by instinct, Rachel brings over two decades of experience in medical development to her role as NeuraMedica’s CEO. Her path has taken her from engineering labs to executive leadership, but the heart of her work has always remained the same.

And that is to use technology to make people’s lives better.

A Simple Idea with Profound Impact

At the center of NeuraMedica’s story is DuraFuse™, an elegantly engineered bioabsorbable clip that offers a safer, faster alternative to traditional sutures for closing the dura mater during spinal surgery.

Designed to reduce the risk of cerebrospinal fluid leaks that come with traditional spinal surgery and improve surgical efficiency, DuraFuse is FDA-cleared and commercially viable. It’s a milestone that only a handful of startups in this corner of the medical space ever reach.

The journey to get there wasn’t simple.

Rachel and her co-founder, neurosurgeon Dr. Neil Roundy, began with a prototype and a bold idea. Backed by grants and early collaborations with Oregon Health & Science University, they methodically advanced their technology through years of clinical research, testing, and refinement.

Leading with Vision and Roots

Rachel is a proud member of the Diné (Navajo) Nation and one of the few Native American women leading a medical technology company. That perspective shapes everything she does, from how she leads her team to how she shows up for the broader community.

She’s a vocal advocate for inclusion in entrepreneurship and STEM, especially for women and Indigenous founders. Her leadership is visible not only inside NeuraMedica but also across Oregon’s startup ecosystem. Rachel frequently participates in regional pitch events, panels, and mentorship programs, where she offers real-world guidance to founders navigating similar hurdles.

Rachel has been recognized for that work, too. NeuraMedica was a finalist for Oregon Entrepreneurs Network’s Angel Oregon Life & Bioscience Investment in 2024. This is a clear sign that the innovation coming out of Mid-Willamette Valley is gaining significant attention.

Meet Rachel at the Oregon Startup Conference

On June 20, 2025, Rachel will be part of the Success Panel of the Oregon Startup Conference at George Fox University.

She does more than represent the future of MedTech. She’s helping to shape it. Her story is a reminder that great startups aren’t only built on good ideas. They’re built on perseverance, collaboration, and a vision that extends beyond the bottom line.

Don’t miss the opportunity to connect with Rachel Dreilinger. She’s someone worth knowing, whether you’re passionate about healthcare innovation, inclusive entrepreneurship, or just want to meet someone who is changing the game in their field.

Register for the Oregon Startup Conference today.